documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
36 rows where docket_id = "FDA-2021-N-0002" and posted_year = 2021 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-0002-0029 | FDA | None FDA-2021-N-0002 | FOI Summary sN 141-452 approved May 18 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:01Z | 0 | 0 | 0900006484e31b69 | |||
| FDA-2021-N-0002-0032 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-702 approved April 23 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:19Z | 0 | 0 | 0900006484e31b6c | |||
| FDA-2021-N-0002-0035 | FDA | None FDA-2021-N-0002 | FOI Summary oN 141-543 approved June 1 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:37Z | 0 | 0 | 0900006484e356c9 | |||
| FDA-2021-N-0002-0024 | FDA | None FDA-2021-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Rule | Final Rule | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T05:00:00Z | 2021-11-08T14:01:16Z | 2021-24075 | 0 | 0 | 0900006484e35459 | |
| FDA-2021-N-0002-0027 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-700 approved June 10 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:50:45Z | 0 | 0 | 0900006484e31b67 | |||
| FDA-2021-N-0002-0036 | FDA | None FDA-2021-N-0002 | FOI Summary sN 140-269 approved May 25 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:43Z | 0 | 0 | 0900006484e356ca | |||
| FDA-2021-N-0002-0028 | FDA | None FDA-2021-N-0002 | FOI Summary sN 128-620 approved June 14 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:50:51Z | 0 | 0 | 0900006484e31b68 | |||
| FDA-2021-N-0002-0026 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-697 approved April 5 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:50:39Z | 0 | 0 | 0900006484e31b66 | |||
| FDA-2021-N-0002-0030 | FDA | None FDA-2021-N-0002 | FOI Summary sN 141-528 approved April 12 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:07Z | 0 | 0 | 0900006484e31b6a | |||
| FDA-2021-N-0002-0031 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-706 approved June 28 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:13Z | 0 | 0 | 0900006484e31b6b | |||
| FDA-2021-N-0002-0033 | FDA | None FDA-2021-N-0002 | FOI Summary sN 139-189 approved April 26 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:25Z | 0 | 0 | 0900006484e31b6d | |||
| FDA-2021-N-0002-0025 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-701 approved June 10 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:50:04Z | 0 | 0 | 0900006484e31b65 | |||
| FDA-2021-N-0002-0034 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-704 approved June 14 2021 RE New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsor Address | Supporting & Related Material | Background Material | 2021-11-08T05:00:00Z | 2021 | 11 | 2021-11-08T14:51:31Z | 0 | 0 | 0900006484e356c8 | |||
| FDA-2021-N-0002-0023 | FDA | None FDA-2021-N-0002 | FOI Summary cN 141-526 approved January 11 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:52Z | 0 | 0 | 0900006484de3d1c | |||
| FDA-2021-N-0002-0006 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-675 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:51Z | 0 | 0 | 0900006484de3d16 | |||
| FDA-2021-N-0002-0010 | FDA | None FDA-2021-N-0002 | FOI Summary sN 141-336 approved January 7 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:52Z | 0 | 0 | 0900006484de3d1b | |||
| FDA-2021-N-0002-0016 | FDA | None FDA-2021-N-0002 | FOI Summary oN 141-539 approved January 15 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:54Z | 0 | 0 | 0900006484de3d22 | |||
| FDA-2021-N-0002-0017 | FDA | None FDA-2021-N-0002 | FOI Summary sN 132-872 approved March 24 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:54Z | 0 | 0 | 0900006484de3d23 | |||
| FDA-2021-N-0002-0018 | FDA | None FDA-2021-N-0002 | FOI Summary oN 141-531 approved March 19 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:54Z | 0 | 0 | 0900006484de3d24 | |||
| FDA-2021-N-0002-0020 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-683 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:55Z | 0 | 0 | 0900006484de3d30 | |||
| FDA-2021-N-0002-0004 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-677 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:51Z | 0 | 0 | 0900006484de3d14 | |||
| FDA-2021-N-0002-0008 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-657 approved February 18 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:51Z | 0 | 0 | 0900006484de3d18 | |||
| FDA-2021-N-0002-0011 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-699 approved March 11 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:53Z | 0 | 0 | 0900006484de3d1d | |||
| FDA-2021-N-0002-0015 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-685 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:54Z | 0 | 0 | 0900006484de3d21 | |||
| FDA-2021-N-0002-0013 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-678 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:53Z | 0 | 0 | 0900006484de3d1f | |||
| FDA-2021-N-0002-0009 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-684 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:52Z | 0 | 0 | 0900006484de3d1a | |||
| FDA-2021-N-0002-0005 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-676 approved January 12 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:51Z | 0 | 0 | 0900006484de3d15 | |||
| FDA-2021-N-0002-0002 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-625 approved March 22 2021 re: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:50Z | 0 | 0 | 0900006484de3d12 | |||
| FDA-2021-N-0002-0007 | FDA | None FDA-2021-N-0002 | FOI Summary cN 141-544 approved January 14 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:51Z | 0 | 0 | 0900006484de3d17 | |||
| FDA-2021-N-0002-0003 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-666 approved February 18 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:51Z | 0 | 0 | 0900006484de3d13 | |||
| FDA-2021-N-0002-0022 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-506 approved February 16 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:51Z | 0 | 0 | 0900006484de3d19 | |||
| FDA-2021-N-0002-0012 | FDA | None FDA-2021-N-0002 | FOI Summary sA 200-466 approved February 8 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:53Z | 0 | 0 | 0900006484de3d1e | |||
| FDA-2021-N-0002-0014 | FDA | None FDA-2021-N-0002 | FOI Summary oN 141-540 Approved February 26 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:53Z | 0 | 0 | 0900006484de3d20 | |||
| FDA-2021-N-0002-0019 | FDA | None FDA-2021-N-0002 | FOI Summary oN 141-530 approved March 15 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:55Z | 0 | 0 | 0900006484de3d25 | |||
| FDA-2021-N-0002-0021 | FDA | None FDA-2021-N-0002 | FOI Summary oA 200-686 approved February 1 2021 RE: New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Supporting & Related Material | Background Material | 2021-10-22T04:00:00Z | 2021 | 10 | 2021-10-26T14:36:55Z | 0 | 0 | 0900006484de3d31 | |||
| FDA-2021-N-0002-0001 | FDA | None FDA-2021-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship | Rule | Final Rule | 2021-10-20T04:00:00Z | 2021 | 10 | 2021-10-20T04:00:00Z | 2021-10-20T15:15:02Z | 2021-22604 | 0 | 0 | 0900006484dcea30 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;